Arthur J. Higgins
2018 - DepoMed
In 2018, Arthur J. Higgins earned a total compensation of $4.8M as President and Chief Executive Officer at DepoMed, which was about the same as previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $754,752 |
|---|---|
| Salary | $800,000 |
| Stock Awards | $3,159,936 |
| Other | $69,339 |
| Total | $4,784,027 |
Higgins received $3.2M in stock awards, accounting for 66% of the total pay in 2018.
Higgins also received $754.8K in non-equity incentive plan, $800K in salary and $69.3K in other compensation.
Rankings
In 2018, Arthur J. Higgins' compensation ranked 2,145th out of 14,244 executives tracked by ExecPay. In other words, Higgins earned more than 84.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,145 out of 14,244 | 85th |
Division Manufacturing | 776 out of 5,765 | 87th |
Major group Chemicals And Allied Products | 258 out of 2,128 | 88th |
Industry group Drugs | 206 out of 1,817 | 89th |
Industry Pharmaceutical Preparations | 159 out of 1,391 | 89th |
Source: SEC filing on April 8, 2019.
Higgins' colleagues
We found six more compensation records of executives who worked with Arthur J. Higgins at DepoMed in 2018.
2018
Stanley Bukofzer
DepoMed
Senior Vice President and Chief Scientific and Technical Officer
2018
Phillip Donenberg
DepoMed
Chief Financial Officer
2018
August Moretti
DepoMed
Chief Financial Officer
2018
Matthew Gosling
DepoMed
General Counsel
2018
Santosh Vetticaden
DepoMed
Chief Medical Officer
2018
Daniel Peisert
DepoMed
Chief Financial Officer
News
Assertio Holdings CEO Arthur Higgins' 2020 pay falls 48% to $2.5M
April 12, 2021
Egalet CEO Arthur Higgins' 2019 pay rises 2% to $4.9M
April 20, 2020
DepoMed CEO Arthur Higgins' 2019 pay rises 2% to $4.9M
April 20, 2020
Egalet CEO Arthur Higgins' 2018 pay stays at $4.8M
November 6, 2019
DepoMed CEO Arthur Higgins' 2018 pay stays at $4.8M
April 8, 2019